A Shocking "Work-From-Home" Trade

A fresh survey from Bank of America (BoA) confirms corporate America’s worst fear — we hate offices! A full 88% of people prefer working from home. While that’s hardly a shocker, the takeaway from BoA analyst Liz Suziki certainly qualifies as one. You see, she believes you should keep buying… read more »

Thursday, December 9, 2021

Mythbusting the Apple Bears (Again)

I know Winston Churchill said, “A lie gets halfway around the world before the truth has a chance to get its pants on…” But not with this guy! You’ll recall that, last week, shares of Apple Inc. (AAPL) suffered a “flash crash” after an unsubstantiated Bloomberg report said demand was… read more »

Tuesday, December 7, 2021

[Emergency Rebroadcast] The Strongest Biotech "Buy" Signal Yet

[Editor’s Note] Just one month ago, Lou predicted that a massive biotech buyout boom was imminent. Well, in the last 24 hours, he uncovered a specific data point. And Lou says this data point “all but guarantees as much as $1.7 trillion is about to be spent buying up compelling… read more »

Thursday, December 2, 2021

The Most Important Chart of the Week

A little gratitude goes a long way. And today, I’m gushing with thankfulness that the biotech sector appeared to bottom out yesterday. Finally! As you know, I’ve been pounding the table to buy biotech stocks for the better part of two years. And the results have been nothing short of… read more »

Wednesday, November 24, 2021

[Charts] Rise of the Machines… And Chip Stocks

It’s Friday in the Trend Trader Daily Nation... That means it’s time to add some excitement to our usual word-based investment analyses. How? By ushering in a handful of charts. If nothing else, charts make it a whole lot faster to digest new information, make some investments — and then… read more »

Friday, November 12, 2021

The Strongest Biotech "Buy" Signal Yet

It all started in late August… That’s when Pfizer Inc. (PFE) paid an unheard of premium of 204% to acquire Trillium Therapeutics (TRIL). About a week later, Sanofi (SNY) swooped in with a $1.9 billion deal for Kadmon Holdings, Inc. (KDMN). Then Merck & Co., Inc. (MRK) jumped into the… read more »

Monday, November 8, 2021

[Charts] Tweets, Chips, and Blatant Robbery

It’s Friday in the Trend Trader Daily Nation. And for the newbies in our midst, here’s what that means: Every Friday, I curate a handful of graphics to convey some important investment insights. All it takes is a quick glance — and you’ll be up to speed and poised to profit.… read more »

Friday, October 29, 2021

38 Billion Reasons to Buy This New Tech

When it comes to investing in emerging technology trends, timing is everything. Too early and there’s a lot of waiting (and losses) involved. Too late and there’s not enough upside remaining. So how do we time our tech investments just right? I shared one foolproof strategy with you before: use… read more »

Thursday, October 21, 2021

An Embarrassing Confession About Peloton

I have a confession to make — and it could make you a ton of money. You see, during the throes of the pandemic, I made the dumbest investment of my career. I knew it was a bad move even at the time. But I did it anyway. And now… read more »

Tuesday, October 19, 2021

[Charts] Earnings Excuses and the Perfect Biotech Set-Up

When Fridays roll around in the Trend Trader Daily Nation, we roll out the charts. All it takes is a quick glance — and you’ll be up to speed and poised to profit from the market’s most important trends. This week, I’m dishing on the implications of the No. 1 excuse… read more »

Friday, October 15, 2021